Collaborate Disseminate
A first-of-its-kind exploratory study, led by researchers from Yale School of Medicine, has found a single dose of the psychedelic psilocybin can reduce migraine frequency by 50 percent for a least two weeks. The preliminary trial was small, with follo… Continue reading Psilocybin & migraine: First of its kind trial reports promising results
Toxoplasmosis is a disease caused by a common parasitic infection. Although it is suspected hundreds of millions of people around the world may be infected with the parasite, only a small volume display symptoms and go on to develop disease.Continue Re… Continue reading How behavior-changing parasites inspire new mental health treatments
A new study, published in the journal Chaos, is suggesting tracking changes over time in the way multiple sclerosis (MS) patients type on their smartphone touchscreens could be a useful method to monitor neurological degeneration.
Tags: Smartphones, Apps, Multiple Sclerosis, Parkinson’s Disease, Neurological, Brain
Continue reading How smartphone typing patterns can track neurodegenerative disease
When someone has experienced a stroke or brain injury, it’s not uncommon for them to lose their ability to swallow properly. A recent study, however, suggests that a new throat-zapping system could help correct the problem faster than traditional treat… Continue reading Throat-zapping tech shown to help treat swallowing disorders
When someone has experienced a stroke or brain injury, it’s not uncommon for them to lose their ability to swallow properly. A recent study, however, suggests that a new throat-zapping system could help correct the problem faster than traditional treat… Continue reading Throat-zapping tech shown to help treat swallowing disorders
A new large-scale analysis of US patient data has found nearly one in five people are diagnosed with a psychiatric illness within three months of a positive COVID-19 test. The Oxford University led study suggests recovered COVID patients are twice as l… Continue reading Oxford study links COVID-19 with increased rates of mental illness
A new large-scale analysis of US patient data has found nearly one in five people are diagnosed with a psychiatric illness within three months of a positive COVID-19 test. The Oxford University led study suggests recovered COVID patients are twice as l… Continue reading Oxford study links COVID-19 with increased rates of mental illness
Robust new research, published in the journal Translational Psychiatry, is reporting on several years of animal studies showing how a psychedelic drug called dimethyltryptamine (DMT) can promote brain plasticity and induce the formation of new neurons…. Continue reading How psychedelic DMT promotes the production of new brain cells
For several years researchers have detected a consistent correlation between depressive symptoms and an increased risk of stroke. A new US study is offering more evidence of the link, presenting data from a longitudinal research project investigating w… Continue reading New evidence furthers link between depression and stroke
A large population-based cohort study, led by researchers from University College London, is suggesting some drugs used to treat diabetes may also prevent the onset of Parkinson’s disease. Along with prior research, these new findings help validate an upcoming Phase 3 human clinical trial set to test one particular diabetes drug in Parkinson’s patients.
Category: Health & Wellbeing, Lifestyle
Tags: Diabetes, Parkinson’s Disease, Glucose, Drugs, Neurological, University College London
Continue reading Diabetes drug found to slow, or in some cases prevent, Parkinson’s